Search research articles
Contact Us
Filters
Showing results (31-40 of 79) with videos related to
Page
of 8
Sort By:
Cancers
|
November 27, 2019
Genetic Mouse Models as In Vivo Tools for Cholangiocarcinoma Research
Oihane Erice, Adrian Vallejo, Mariano Ponz-Sarvise, et al.
Journal of Cancer Research and Clinical Oncology
|
August 26, 2021
Molecular diagnostics and therapies for gastrointestinal tumors: a real-world experience
Sabrina Welland, Tiago deCastro, Melanie Bathon, et al.
Genes & Development
|
January 8, 2014
A modular and flexible ESC-based mouse model of pancreatic cancer
Michael Saborowski, Anna Saborowski, John P Morris, et al.
JHEP Reports : Innovation in Hepatology
|
February 21, 2025
Recent advances in systemic therapy for advanced biliary tract cancer: A systematic review and meta-analysis using reconstructed RCT survival data
Zhihao Li, Daniel Aliseda, Owen Jones, et al.
Nature Reviews. Clinical Oncology
|
March 3, 2026
Perioperative approaches for patients with biliary tract cancer
Anudari Zorigtbaatar, Zhihao Li, Christian T J Magyar, et al.
Clinical & Experimental Metastasis
|
November 23, 2022
New perspectives in unresectable cholangiocarcinoma? Evaluation of chemosaturation with percutaneous hepatic perfusion as a palliative treatment option
Cornelia L A Dewald, Lena S Becker, Timo C Meine, et al.
The EMBO Journal
|
September 13, 2012
A complex immunodeficiency is based on U1 snRNP-mediated poly(A) site suppression
Jörg Langemeier, Eva-Maria Schrom, Alona Rabner, et al.
Cancers
|
January 11, 2022
Percutaneous Hepatic Perfusion (PHP) with Melphalan in Liver-Dominant Metastatic Uveal Melanoma: The German Experience
Cornelia L A Dewald, Mia-Maria Warnke, Roland Brüning, et al.
Pathologie (Heidelberg, Germany)
|
February 19, 2024
[The model transferability of AI in digital pathology : Potential and reality]
Robin S Mayer, Maximilian N Kinzler, Alexandra K Stoll, et al.
Cancers
|
December 5, 2019
Potent Antitumor Activity of Liposomal Irinotecan in an Organoid- and CRISPR-Cas9-Based Murine Model of Gallbladder Cancer
Zulrahman Erlangga, Katharina Wolff, Tanja Poth, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 79) with videos related to
Sort By:
Page
of 8
Cancers
|
November 27, 2019
Genetic Mouse Models as In Vivo Tools for Cholangiocarcinoma Research
Oihane Erice, Adrian Vallejo, Mariano Ponz-Sarvise, et al.
Journal of Cancer Research and Clinical Oncology
|
August 26, 2021
Molecular diagnostics and therapies for gastrointestinal tumors: a real-world experience
Sabrina Welland, Tiago deCastro, Melanie Bathon, et al.
Genes & Development
|
January 8, 2014
A modular and flexible ESC-based mouse model of pancreatic cancer
Michael Saborowski, Anna Saborowski, John P Morris, et al.
JHEP Reports : Innovation in Hepatology
|
February 21, 2025
Recent advances in systemic therapy for advanced biliary tract cancer: A systematic review and meta-analysis using reconstructed RCT survival data
Zhihao Li, Daniel Aliseda, Owen Jones, et al.
Nature Reviews. Clinical Oncology
|
March 3, 2026
Perioperative approaches for patients with biliary tract cancer
Anudari Zorigtbaatar, Zhihao Li, Christian T J Magyar, et al.
Clinical & Experimental Metastasis
|
November 23, 2022
New perspectives in unresectable cholangiocarcinoma? Evaluation of chemosaturation with percutaneous hepatic perfusion as a palliative treatment option
Cornelia L A Dewald, Lena S Becker, Timo C Meine, et al.
The EMBO Journal
|
September 13, 2012
A complex immunodeficiency is based on U1 snRNP-mediated poly(A) site suppression
Jörg Langemeier, Eva-Maria Schrom, Alona Rabner, et al.
Cancers
|
January 11, 2022
Percutaneous Hepatic Perfusion (PHP) with Melphalan in Liver-Dominant Metastatic Uveal Melanoma: The German Experience
Cornelia L A Dewald, Mia-Maria Warnke, Roland Brüning, et al.
Pathologie (Heidelberg, Germany)
|
February 19, 2024
[The model transferability of AI in digital pathology : Potential and reality]
Robin S Mayer, Maximilian N Kinzler, Alexandra K Stoll, et al.
Cancers
|
December 5, 2019
Potent Antitumor Activity of Liposomal Irinotecan in an Organoid- and CRISPR-Cas9-Based Murine Model of Gallbladder Cancer
Zulrahman Erlangga, Katharina Wolff, Tanja Poth, et al.
Page
of 8